J&J Buys Russian Cold Drug Brands For $260M

Law360, New York (May 23, 2011, 3:08 PM EDT) -- Johnson & Johnson kept up its vigorous buying spree Monday, announcing that its Swiss-based Cilag GmbH International unit is buying several leading cough and cold medicine brands in Russia from Mumbai-based J.B. Chemicals & Pharmaceuticals Ltd. for $260 million.

Johnson & Johnson LLC and its affiliates will market Rinza and Doktor Mom, two of Russia's leading over-the-counter brands, as well as several others, the New Jersey-based pharmaceutical giant said Monday.

The deal shows J&J continues to look eastward after pulling the trigger on a stock-heavy, $21.3...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.